Rankings
▼
Calendar
FLGT FY 2020 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$458M
FY 2020 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$422M
+1196.5% YoY
Gross Profit
$332M
78.7% margin
Operating Income
$290M
68.8% margin
Net Income
$214M
50.8% margin
EPS (Diluted)
$8.91
Cash Flow
Operating Cash Flow
$141M
Free Cash Flow
$104M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$700M
Total Liabilities
$131M
Stockholders' Equity
$569M
Cash & Equivalents
$87M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$422M
$33M
+1196.5%
Gross Profit
$332M
$18M
+1701.8%
Operating Income
$290M
-$428,000
+67893.9%
Net Income
$214M
-$411,000
+52243.6%
← Q4 2019
All Quarters
Q1 2020 →